Global Pertussis Vaccine Market to Reach $6.62 Billion by 2029, Growing at 3.7% CAGR

What Is the Expected Size and Growth Rate of the Pertussis Vaccine Market?
The pertussis vaccine market has experienced steady growth in recent years. It will grow from $5.5 billion in 2024 to $5.72 billion in 2025, at a compound annual growth rate (CAGR) of 4.1%. This growth is attributed to factors such as the prevalence of the disease, immunization programs, pediatric vaccination efforts, and regulatory approvals.

The pertussis vaccine market is projected to experience steady growth over the next few years, reaching $6.62 billion by 2029 with a compound annual growth rate (CAGR) of 3.7%. This growth is driven by factors such as booster vaccinations, maternal immunization, healthcare worker immunization, and global health initiatives. Key trends include personalized vaccination schedules, combination vaccines, vaccine equity programs, and the use of digital health technologies for immunization.

What Factors Are Fueling Growth in the Pertussis Vaccine Market?
The increasing birth rates are contributing to the expansion of the pertussis vaccine market. Childbirth refers to the process of delivering a baby, marking the culmination of pregnancy when the fetus is born. The pertussis vaccine is primarily administered to children to protect them from whooping cough and other severe, potentially life-threatening diseases. For example, in January 2023, a report by the Centers for Disease Control and Prevention (CDC), a US-based national public health organization, revealed that the United States recorded a 1% rise in registered births, totaling 3,664,292 compared to the previous year. As a result, the rising childbirth rates are driving the expansion of the pertussis vaccine market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Leading Companies Are Shaping the Growth of the Pertussis Vaccine Market?
Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

What Are the Major Trends Shaping the Pertussis Vaccine Market?
Major companies in the pertussis vaccine market are focusing on developing new vaccines and securing regulatory approvals to strengthen their market position. For example, in October 2022, GSK plc., a UK-based pharmaceutical and biotechnology firm, announced the approval of BOOSTRIX by the U.S. Food and Drug Administration (FDA). BOOSTRIX is a Tdap vaccine containing tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis components. It is administered via a single injection into the upper arm and is proven to be both safe and effective in preventing pertussis, including severe cases, in newborns when given to pregnant women.

What Are the Key Segments of the Pertussis Vaccine Market?
The pertussis vaccine market covered in this report is segmented -

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Region Dominates the Pertussis Vaccine Market?
North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Pertussis Vaccine Global Market Report?

- Market Size Analysis: Analyze the Pertussis Vaccine Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pertussis Vaccine Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pertussis Vaccine Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pertussis Vaccine Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.